The significance of plasma protein binding on the fetal/maternal distribution of drugs at steady-state.
about
The effects of maternally administered methadone, buprenorphine and naltrexone on offspring: review of human and animal data.The acquisition and application of absorption, distribution, metabolism, and excretion (ADME) data in agricultural chemical safety assessments.Protein binding of propranolol and verapamil enantiomers in maternal and foetal serumPlasma protein binding of disopyramide in pregnant and postpartum women, and in neonates and their mothers.Pharmacokinetics of fluoxetine in pregnant baboons (Papio spp.).Diabetes and hypertension increase the placental and transcellular permeation of the lipophilic drug diazepam in pregnant women.Clinical therapeutics in pregnancy.Effect of plasma proteins on buprenorphine transfer across dually perfused placental lobule.Prediction and evaluation of fetal toxicity induced by NSAIDs using transplacental kinetic parameters obtained from human placental perfusion studies.Children's susceptibility to chemicals: a review by developmental stage.Differential protein binding of indinavir and saquinavir in matched maternal and umbilical cord plasma.Tacrolimus placental transfer at delivery and neonatal exposure through breast milk.The human placental perfusion model: a systematic review and development of a model to predict in vivo transfer of therapeutic drugs.Fetal serotonin reuptake inhibitor antidepressant exposure: maternal and fetal factors.Gender-specific differences in the central nervous system's response to anesthesia.Disposition of desfuroylceftiofur acetamide in serum, placental tissue, fetal fluids, and fetal tissues after administration of ceftiofur crystalline free acid (CCFA) to pony mares with placentitis.Development of a Novel Maternal-Fetal Physiologically Based Pharmacokinetic Model I: Insights into Factors that Determine Fetal Drug Exposure through Simulations and Sensitivity Analyses.Development of a Novel Maternal-Fetal Physiologically Based Pharmacokinetic Model II: Verification of the model for passive placental permeability drugs.In vivo determinations of carbamazepine and carbamazepine-10, 11-epoxide binding parameters to serum proteins in monotherapy patients.
P2860
Q30490602-E11F8B42-0BE9-4827-A091-CF0D11C9FB9FQ31041215-07DBAFBA-C248-42F6-BDE8-3E1CC9CB6074Q34346873-6EB795DA-E687-4E1B-AA19-1E1F768C263EQ34398308-C465FB9A-7EE0-4657-8943-AE21F41B5FE3Q34620074-80983AF5-38FD-46AB-A0F4-54F0434F1F3CQ35019769-8D5EC633-9B3F-4542-948D-05F2D5DAE17CQ35113890-371A3578-497F-4321-B9D6-7F3458C96DCDQ35618710-83707AAF-168E-42F7-9DF8-00AEF931B1DAQ35718609-0F47BE51-1E78-4F1C-BAF1-572C1AABFDFAQ35977793-78883D10-0CDA-463D-B722-D4B37CA29F4EQ36025069-74FD7C6B-A565-4D99-BE1D-382FE92DB48EQ37353469-530D507A-7547-484B-9B3D-C35662D42C2BQ37874439-3C920CFD-B1C2-4DB1-B722-99E6FBCE010BQ38052726-F6B4B108-9C6C-401F-9230-AE391313EBA4Q38170002-B04FAA79-B70E-441A-8880-9D517921DF33Q47981606-CD8CC779-1134-467E-BBCB-7B1CF88151C1Q50597914-CDCDCD06-6481-4322-8B9F-375AB027B1F4Q50974898-C7E594B0-2198-4B9E-8709-2424709EF4B2Q52391484-A3918B25-DBF1-4596-9BBC-5176BD4F26C3
P2860
The significance of plasma protein binding on the fetal/maternal distribution of drugs at steady-state.
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
1988年论文
@zh
1988年论文
@zh-cn
name
The significance of plasma pro ...... tion of drugs at steady-state.
@en
The significance of plasma pro ...... tion of drugs at steady-state.
@nl
type
label
The significance of plasma pro ...... tion of drugs at steady-state.
@en
The significance of plasma pro ...... tion of drugs at steady-state.
@nl
prefLabel
The significance of plasma pro ...... tion of drugs at steady-state.
@en
The significance of plasma pro ...... tion of drugs at steady-state.
@nl
P1476
The significance of plasma pro ...... tion of drugs at steady-state.
@en
P2093
F P Abramson
P304
P356
10.2165/00003088-198814030-00004
P577
1988-03-01T00:00:00Z
P6179
1005036807